Abstract
THIS REPORT:
- Offers a thorough review of the global market for contract manufacturing,
research and packaging in the pharmaceutical business
- Provides the current global market status for contract manufacturing,
research, and packaging and forecasts for growth through 2014
- Discusses the advantages and disadvantages of outsourcing
- Covers technological issues including the latest trends and developments
- Describes the regulatory environment.
STUDY OBJECTIVES
BCC' s goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for contract manufacturing,
research, and packaging in the pharmaceuticals industry. The key objective is
to present a comprehensive analysis of the current market and its future
direction in the pharmaceuticals and biotechnology outsourcing industry with
the emphasis on contract manufacturing.
This report explores present and future strategies within the contract
manufacturing, research, and packaging pharmaceuticals industry. The needs,
services offered, criteria for selection, and the advantages of outsourcing
are discussed. The study also includes the need for project management, market
forecasts and a discussion of the market leaders in the industry. Regulatory
requirements and current state of the outsourcing market in the
pharmaceuticals and biotechnology industry are also portrayed in this report.
A detailed analysis of the pharmaceutical-biopharmaceutical contract
manufacturing, research, and packaging industry structure has been conducted.
Revenues are broken down by bulk as well as by dosage forms of solid, liquid,
and semisolid pharmaceuticals. Sales figures are estimated for the 5 year
period from 2009 through 2014.
Over-the-counter (OTC), nutritional, and drug-delivery products are discussed
separately in this report. Contract research and contract packaging are also
discussed separately
SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and
packaging markets. BCC analyzes each market and its applications by its need
for outsourcing, regulatory environment, technology involved, market
projections, and market share. Technological issues include the latest trends
and developments.
METHODOLOGY
BCC conducted a comprehensive literature search, which included technical
newsletters and journals, and many other sources. Data were collected through
interviews and correspondence with various analytical, chemical,
pharmaceutical, and contracting experts. Projections were based on estimates
such as the current number of end users, potential end users, mergers and
acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this
study. Included were manufacturers and end users of pharmaceuticals through
contract manufacturing and research. Data were gathered from various industry
sources. BCC spoke with officials and physicians within the industry, and
consulted newsletters, company literature, product literature, and a host of
technical articles, journals, indexes, and abstracts. Exhaustive
investigations of databases by key terminology were completed. In addition,
data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
Shalini S. Dewan holds a master' s degree in pharmaceutical chemistry. Among
the research topics she has covered are studies on compounds of potential
pharmaceutical interest, from ibuprofen and 2-naphthyl acetic acid. Shalini
was awarded a Gold Medal by the Prime Minister of India for her work and has
worked with top companies in India and in the U.S. Some of her other reports
with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market;
Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices;
Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents
Used in Biotechnology.
|